Pricing Log in Create free account

Adagene Inc. Sponsored ADR (ADAG) vs Cue Biopharma, Inc. (CUE)

Adagene Inc. Sponsored ADR and Cue Biopharma, Inc. are both Biotechnology companies. Adagene Inc. Sponsored ADR and Cue Biopharma, Inc. are of similar size ($136.1M and $134.3M). Across the 9 metrics below, Adagene Inc. Sponsored ADR leads on 6 and Cue Biopharma, Inc. on 3.

Valuation

Metric ADAG CUE Biotechnology median
P/E — n/m 10.60
P/S — 3.15 9.40
P/B n/m 51.41 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 2.74 9.02
Earnings yield — (143.53%) (32.88%)
Free cash flow yield 0.00% (42.21%) (23.13%)

Profitability

Metric ADAG CUE Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin — (262.03%) 0.00%
Net margin — (435.83%) 0.00%
Free cash flow margin 0.00% (133.13%) 0.00%
Return on equity 0.00% (1,603.48%) (51.96%)
Return on assets 0.00% (459.60%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADAG CUE Biotechnology median
Revenue growth (TTM) — 354.37% 6.76%
EPS growth (last fiscal year) 49.15% 61.11% 29.88%
Revenue growth, 5-year CAGR 61.38% 54.16% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADAG CUE Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 5.02 1.25 4.97
Net debt to EBITDA 3.46 1.10 1.01

Dividend

Metric ADAG CUE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ADAG CUE Biotechnology median
Market cap 134.28m 136.06m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack